These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10885496)

  • 1. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
    Briseid K; Lygren I; Johannesen S; Marthinsen K
    Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein modification with affinity to IgG present in higher amounts than normal in plasma from patients with Crohn's disease.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2003; 63(6):425-9. PubMed ID: 14594323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Part of prekallikrein removed from human plasma together with IgG--immunoblot experiments and functional tests.
    Briseid K; Hoem NO; Johannesen S
    Scand J Clin Lab Invest; 1999 Feb; 59(1):55-63. PubMed ID: 10206098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2002; 62(1):21-4. PubMed ID: 12002409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of IgG for the activity of factor XII measured in human plasma.
    Briseid K; Hoem NO; Johannesen S; Vangen AM; Westgaard T
    Scand J Clin Lab Invest; 1996 Dec; 56(8):725-34. PubMed ID: 9034354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amidolytic assay of factor XI in human plasma--significance of kallikrein for the activity measured.
    Briseid K; Hoem NO; Johannesen S; Haug K
    Thromb Res; 1995 May; 78(3):239-50. PubMed ID: 7631304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
    Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
    Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy.
    Fossum S; Hoem NO; Gjønnaess H; Briseid K
    Thromb Res; 1999 Feb; 93(4):161-70. PubMed ID: 10064271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors XI and XII and prekallikrein in sick and healthy premature infants.
    Andrew M; Bhogal M; Karpatkin M
    N Engl J Med; 1981 Nov; 305(19):1130-3. PubMed ID: 6912944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preparation of a prekallikrein concentrate and determination of its activator in blood derivatives].
    Simonianová E
    Cesk Farm; 1992 Feb; 41(1):8-9. PubMed ID: 1586974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly of contact-phase factors on the surface of the human neutrophil membrane.
    Henderson LM; Figueroa CD; Müller-Esterl W; Bhoola KD
    Blood; 1994 Jul; 84(2):474-82. PubMed ID: 8025275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contact coagulation factors].
    Kojima T; Saito H
    Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced specificity of immunoblotting using radiolabeled antigen overlay: studies of blood coagulation factor XII and prekallikrein in plasma.
    Lämmle B; Berrettini M; Griffin JH
    Anal Biochem; 1986 Jul; 156(1):118-25. PubMed ID: 3638135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril.
    Patrassi GM; Fallo F; Martinelli S; Mantero F; Boeri G; Girolami A
    Eur Heart J; 1984 Jul; 5(7):561-7. PubMed ID: 6383834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.